MedTrace Logo

Extrapulmonary Interventional Ventilatory Support in Severe Acute Respiratory Distress Syndrome (ARDS)

NCT00538928 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2011-03-02

No results posted yet for this study

Summary

A prospective, randomized study will be performed investigating the effects of a pumpless extracorporeal interventional lung assist \[iLA\] on the implementation of a lung-protective ventilatory strategy in patients with acute respiratory distress syndrome \[ARDS\] with a PaO2/FiO2 ratio \< 200. The duration of ventilation, intensive care and hospital stay and in-hospital mortality will be investigated.

Conditions

  • Acute Respiratory Distress Syndrome

Interventions

OTHER

lung protective ventilation

tidal volume 6 ml/kg ideal body weight

Sponsors & Collaborators

  • Charite University, Berlin, Germany

    collaborator OTHER

  • University of Regensburg

    lead OTHER

Principal Investigators

  • Thomas Bein, Professor Dr. · University Hospital Regensburg

  • Steffen Weber-Carstens, Dr. · Charite University Hospital Berlin

  • Thomas Staudinger, Prof · University Hospital Vienna, Austria

  • Sven Bercker, MD · University Hospital Leipzig, Germany

  • Ralph Müllenbach, MD PhD · University Hospital Würzburg, Germany

  • Rolf Dembinski, MD PhD · University Hospital Aachen, Germany

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-09-30
Primary Completion
2011-01-31
Completion
2011-01-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00538928 on ClinicalTrials.gov